Number of the records: 1  

IrC2/Bf - A yeast and Borrelia responsive component of the complement system from the hard tick Ixodes ricinus

  1. 1.
    SYSNO ASEP0489065
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleIrC2/Bf - A yeast and Borrelia responsive component of the complement system from the hard tick Ixodes ricinus
    Author(s) Urbanová, V. (CZ)
    Hajdušek, O. (CZ)
    Šíma, R. (CZ)
    Franta, Z. (CZ)
    Hönig Mondeková, Helena (MBU-M)
    Grunclová, L. (CZ)
    Bartošová-Sojková, P. (CZ)
    Jalovecká, M. (CZ)
    Kopáček, P. (CZ)
    Source TitleDevelopmental and Comparative Immunology. - : Elsevier - ISSN 0145-305X
    Roč. 76, FEB 2018 (2018), s. 86-94
    Number of pages9 s.
    Languageeng - English
    CountryGB - United Kingdom
    KeywordsBorrelia ; C3-complement convertase ; Factor B
    Subject RIVEE - Microbiology, Virology
    OECD categoryMicrobiology
    Institutional supportMBU-M - RVO:61388971
    UT WOS000422811500010
    EID SCOPUS85032298274
    DOI https://doi.org/10.1016/j.dci.2017.10.012
    AnnotationTicks possess components of a primordial complement system that presumably play a role in the interaction of the tick immune system with tick-borne pathogens and affect their transmission. Here we characterized a novel complement component, tagged as IrC2/Bf, from the hard tick Ixodes ricinus, the principal vector of Lyme disease in Europe. IrC2/Bf is a multi-domain molecule composed of 5-7 CCP modules, varied by alternative splicing, followed by a von Willebrand factor A domain and a C-terminal trypsin-like domain. The primary structure and molecular architecture of IrC2/Bf displays the closest homology to the C3-complement component convertases described in horseshoe crabs. The irc2/bf gene is mainly expressed in the tick fat body associated with the trachea and, as determined by western blotting, the protein is present in low amounts in tick hemolymph. Expression of irc2/bf mRNA was significantly up-regulated in response to the intra-hemocoelic injection of the yeast Candida albicans and all tested Borrelia sp. strains (B. burgdorferi NE5264, B. burgdorferi CB26, B. garinii IVISLB, B. afzelii CB43), but was not affected by injection of model Gram-negative and Gram-positive bacteria or the aseptic injection control. In-line with these results, RNAi-mediated silencing of irc2/bf inhibited phagocytosis of B. afzelii and C. albicans but not the other bacteria. Tissue expression profiles, specific responses to microbial challenges, and patterns of phagocytic phenotypes upon RNAi silencing observed for IrC2/Bf match well with the previously reported characteristics of I. ricinus C3-related molecule 1 (IrC3-1). Therefore we presume that IrC2/Bf functions as a convertase in the same complement activation pathway protecting ticks against yeast and Borrelia infection.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2019
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.